Compare
2 stocks, side by sideRelative performance · rebased to 100
ALNYMRNA
Pair ratio · ALNY ÷ MRNARelative value, rich or cheap vs their own history
The price ratio ALNY ÷ MRNA with its 1Y mean and ±1σ / ±2σ bands; the z-score is how far the ratio sits from its average. A stretched reading flags one stock as rich vs the other relative to their history, but mean-reversion isn't guaranteed (a durable re-rating from better growth or margins can keep the ratio elevated). Research tooling, not advice.
| ALNYAlnylam Pharmaceuticals, Inc. | MRNAModerna | |
|---|---|---|
| Smart Score | 8/10 | 9/10 |
| Price | $293.17 | $60.42 |
| 1 month | -0.79% | +29% |
| 1 year | -9.8% | +135% |
| 5 year | +70% | -69% |
| P/E (TTM) | 67.8 | -7.4 |
| P/E vs sector | +115% | - |
| Market cap | $39.1B | $25.4B |
| Sector | Healthcare | Health Care |
Risk / Return · past yearAnnualized return vs volatility, up-and-left is more reward for less risk.
Correlation · do they move together?Pairwise daily-return correlation over the past year, high = one bet, low = diversifying.